75 related articles for article (PubMed ID: 22639157)
1. Standard therapy or additionally radioactive iodine (131I) therapy; which will stop the recurrence of glioblastoma multiforme (GBM)?
Czarnywojtek A; Gut P; Dyrka K; Sowiński J; Sawicka-Gutaj N; Katulska K; Stajgis P; Wykrętowicz M; Moskal J; Kościński J; Pietrończyk K; Graczyk P; Krawczyński MR; Florek E; Szczepanek-Parulska E; Ruchała M; Ferlito A
Endokrynol Pol; 2024; 75(2):130-139. PubMed ID: 38646982
[TBL] [Abstract][Full Text] [Related]
2. Combining drugs and radiotherapy: from the bench to the bedside.
Palanichamy K; Chakravarti A
Curr Opin Neurol; 2009 Dec; 22(6):625-32. PubMed ID: 19770758
[TBL] [Abstract][Full Text] [Related]
3. Point/counterpoint: randomized versus single-arm phase II clinical trials for patients with newly diagnosed glioblastoma.
Grossman SA; Schreck KC; Ballman K; Alexander B
Neuro Oncol; 2017 Apr; 19(4):469-474. PubMed ID: 28388713
[No Abstract] [Full Text] [Related]
4. Validation of multiparametric MRI based prediction model in identification of pseudoprogression in glioblastomas.
de Godoy LL; Mohan S; Wang S; Nasrallah MP; Sakai Y; O'Rourke DM; Bagley S; Desai A; Loevner LA; Poptani H; Chawla S
J Transl Med; 2023 Apr; 21(1):287. PubMed ID: 37118754
[TBL] [Abstract][Full Text] [Related]
5. Emerging MR Imaging and Spectroscopic Methods to Study Brain Tumor Metabolism.
Kumar M; Nanga RPR; Verma G; Wilson N; Brisset JC; Nath K; Chawla S
Front Neurol; 2022; 13():789355. PubMed ID: 35370872
[TBL] [Abstract][Full Text] [Related]
6. Challenges and Therapeutic Opportunities of Autophagy in Cancer Therapy.
Silva VR; Neves SP; Santos LS; Dias RB; Bezerra DP
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33233671
[TBL] [Abstract][Full Text] [Related]
7. At the Bench: Pre-clinical evidence for multiple functions of CXCR4 in cancer.
Luker GD; Yang J; Richmond A; Scala S; Festuccia C; Schottelius M; Wester HJ; Zimmermann J
J Leukoc Biol; 2021 May; 109(5):969-989. PubMed ID: 33104270
[TBL] [Abstract][Full Text] [Related]
8. Reduced EGFR and increased miR-221 is associated with increased resistance to temozolomide and radiotherapy in glioblastoma.
Areeb Z; Stuart SF; West AJ; Gomez J; Nguyen HPT; Paradiso L; Zulkifli A; Jones J; Kaye AH; Morokoff AP; Luwor RB
Sci Rep; 2020 Oct; 10(1):17768. PubMed ID: 33082482
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional echo planar spectroscopic imaging for differentiation of true progression from pseudoprogression in patients with glioblastoma.
Verma G; Chawla S; Mohan S; Wang S; Nasrallah M; Sheriff S; Desai A; Brem S; O'Rourke DM; Wolf RL; Maudsley AA; Poptani H
NMR Biomed; 2019 Feb; 32(2):e4042. PubMed ID: 30556932
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-derived exosomes induce putative altered pathways in biosynthesis and ion regulatory channels in glioblastoma cells.
Kore RA; Edmondson JL; Jenkins SV; Jamshidi-Parsian A; Dings RPM; Reyna NS; Griffin RJ
Biochem Biophys Rep; 2018 Jul; 14():104-113. PubMed ID: 29872742
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of glioblastoma cell proliferation, migration and invasion by the proteasome antagonist carfilzomib.
Areeb Z; Stylli SS; Ware TM; Harris NC; Shukla L; Shayan R; Paradiso L; Li B; Morokoff AP; Kaye AH; Luwor RB
Med Oncol; 2016 May; 33(5):53. PubMed ID: 27098175
[TBL] [Abstract][Full Text] [Related]
12. Formononetin sensitizes glioma cells to doxorubicin through preventing EMT via inhibition of histone deacetylase 5.
Liu Q; Sun Y; Zheng JM; Yan XL; Chen HM; Chen JK; Huang HQ
Int J Clin Exp Pathol; 2015; 8(6):6434-41. PubMed ID: 26261519
[TBL] [Abstract][Full Text] [Related]
13. Mammaglobin-A immunohistochemistry in primary central nervous system neoplasms and intracranial metastatic breast carcinoma.
Cimino PJ; Perrin RJ
Appl Immunohistochem Mol Morphol; 2014 Jul; 22(6):442-8. PubMed ID: 23958549
[TBL] [Abstract][Full Text] [Related]
14. The role of AEG-1/MTDH/LYRIC in the pathogenesis of central nervous system disease.
Noch EK; Khalili K
Adv Cancer Res; 2013; 120():159-92. PubMed ID: 23889991
[TBL] [Abstract][Full Text] [Related]
15. Organotypic slice cultures of human glioblastoma reveal different susceptibilities to treatments.
Merz F; Gaunitz F; Dehghani F; Renner C; Meixensberger J; Gutenberg A; Giese A; Schopow K; Hellwig C; Schäfer M; Bauer M; Stöcker H; Taucher-Scholz G; Durante M; Bechmann I
Neuro Oncol; 2013 Jun; 15(6):670-81. PubMed ID: 23576601
[TBL] [Abstract][Full Text] [Related]
16. Recent medical management of glioblastoma.
Johnson DR; Chang SM
Adv Exp Med Biol; 2012; 746():26-40. PubMed ID: 22639157
[TBL] [Abstract][Full Text] [Related]
17. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
[TBL] [Abstract][Full Text] [Related]
18. Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme.
Athanassiou H; Synodinou M; Maragoudakis E; Paraskevaidis M; Verigos C; Misailidou D; Antonadou D; Saris G; Beroukas K; Karageorgis P
J Clin Oncol; 2005 Apr; 23(10):2372-7. PubMed ID: 15800329
[TBL] [Abstract][Full Text] [Related]
19. Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy.
Affronti ML; Heery CR; Herndon JE; Rich JN; Reardon DA; Desjardins A; Vredenburgh JJ; Friedman AH; Bigner DD; Friedman HS
Cancer; 2009 Aug; 115(15):3501-11. PubMed ID: 19514083
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
